110

News

Novo Nordisk to sell affordable insulin in developing nations

Christian Wenande
September 23rd, 2016


This article is more than 8 years old.

Majority of the 415 million people suffering from diabetes worldwide live in low and middle-income nations

50 million people lack access to insulin worldwide (photo: Novo Nordisk)

Insulin produced by the Danish biotech company Novo Nordisk will be a fraction of the price in developing nations compared to the West.

The news comes in the wake of CEO Lars Rebien Sørensen being part of a panel at the UN General Assembly in New York.

“Some 415 million people suffer from diabetes worldwide. Most live in low and middle-income countries. An estimated 50 million people lack access to insulin worldwide,” the company wrote.

“It is our ambition to continue being the leading supplier of low-priced human insulin in the world. We wish to provide affordable insulin treatment to significantly more patients in developing countries, and we are committed to passing on possible future gains in production efficiency to patients.”

READ MORE: Lars Rebien Sørensen to step down as head of Novo Nordisk

Starting in 2017
Novo Nordisk will ensure the price of medicine does not exceed 20 percent of the list prices that patients in Western nations pay for human insulin, and the figure will be decided by Novo Nordisk’s Social and Environmental Committee.

Novo Nordisk produces nearly half of the world’s insulin supply, and its guarantee applies to nations among the Least Developed Countries as defined by the UN and the World Bank.

The biotech giant’s ‘Access to Insulin Commitment’ will come into effect as of 2017.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”